Theranexus (EPA:ALTHX)

PRESS RELEASE

published on 05/13/2025 at 18:00, 11 months 21 days ago

THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-WORLD DATA SUPPORTING BATTEN-1 EFFICACY FOR THE TREATMENT OF BATTEN DISEASE
Theranexus and BBDF announce new data supporting Batten-1 (miglustat) efficacy for CLN3 disease treatment. Results show significant preservation of visual acuity in treated patients over 12 months. Real-world analysis aligns with Phase 3 trial design

Theranexus Batten-1 BBDF Visual Acuity CLN3 Disease
BRIEF

published on 04/29/2025 at 19:05, 1 year ago

Theranexus: 2024 Annual Review and New Perspectives

Financial Results Partnerships Theranexus Batten-1 Grants
PRESS RELEASE

published on 04/29/2025 at 19:00, 1 year ago

THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
Theranexus publishes financial results for 2024 & cash position as of March 31, 2025, presents progress report & plans for Batten-1 drug candidate. Board approves accounts. Continues strategic partnerships & developments

Financial Results Strategic Partnerships Clinical Trials Theranexus Batten-1
BRIEF

published on 03/06/2025 at 18:05, 1 year 1 month ago

Modification of the Theranexus liquidity contract

Liquidity Contract AMF PORTZAMPARC Theranexus Rare Neurological Diseases
BRIEF

published on 01/31/2025 at 18:10, 1 year 3 months ago

Half-yearly report on Theranexus' liquidity contract with Portzamparc

Liquidity Contract Transactions PORTZAMPARC Half-yearly Report Theranexus
BRIEF

published on 01/30/2025 at 18:05, 1 year 3 months ago

Theranexus Strengthens its Treasury and Develops its Partnerships

Treasury Theranexus Neurological Diseases Exeltis Partnership Bpifrance Financing
PRESS RELEASE

published on 01/30/2025 at 18:00, 1 year 3 months ago

THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2024 AND PRESENTS ITS PROGRESS REPORT
Theranexus announces cash position of €4.0 M as of 29 January 2025, strengthening financial outlook. Biopharmaceutical company progressing on rare neurological disease treatments, including Niemann-Pick and Gaucher diseases

Cash Position Biopharmaceutical Financial Outlook Theranexus Neurological Diseases
BRIEF

published on 01/23/2025 at 18:20, 1 year 3 months ago

Theranexus Unveils 2025 Financial Calendar

Financial Calendar Biopharmaceutical Theranexus Neurological Diseases 2025 Schedule
PRESS RELEASE

published on 01/23/2025 at 18:15, 1 year 3 months ago

THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025
Theranexus, a biopharmaceutical company in rare neurological disease treatment, announces its 2025 financial communication agenda for Euronext market. Dates subject to change

Euronext Biopharmaceutical Financial Communication Theranexus Neurological Diseases
BRIEF

published on 01/23/2025 at 18:05, 1 year 3 months ago

Theranexus Announces its Financial Agenda for 2025

Euronext Paris Financial Agenda Theranexus Financial Publications Neurological Diseases

Published on 05/02/2026 at 21:00, 1 day ago

GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 19 hours ago

Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 20 hours ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 21 hours ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 21 hours ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

View all ACCESSWIRE

Published on 05/03/2026 at 20:10, 56 minutes ago

A Decade of Learning Across Borders: PKU's South-South Institute Turns 10
Published on 05/03/2026 at 04:45, 16 hours 21 minutes ago

GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 1 day 5 hours ago

Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 2 days 1 hour ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 2 days 2 hours ago

Holding(s) in Company

View all EQS

Published on 04/30/2026 at 20:00, 3 days 1 hour ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 3 days 1 hour ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 3 days 2 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 3 days 2 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 3 days 3 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News